Living meta-analysis and evidence synthesis of therapies for COVID-19

click on circles to display study description...

LIFESAVER, 2021 NCT04374526

convalescent plasma treatment (n=4) vs. standard of care (n=8)

randomized controlled trial   low risk of bias

Studied treatment

Convalescent plasma

Control treatment

Standard of care

Patients

COVID 19 all comers

Method

Open-label.

Italy.

Remark

Study not published yet. Results and risk of bias assessment were extracted from Axfors C. et al meta-analysis https://bmcinfectdis.biomedcentral.com/articles/10.1186/s12879-021-06829-7?s=09.